Immunology and Microbiology
Pneumococcus
100%
Minimum Inhibitory Concentration
35%
Maximum Concentration
28%
Drug Hypersensitivity
28%
Dose
21%
Haemophilus influenzae
7%
Streptococcus Pneumoniae
7%
Moraxella catarrhalis
7%
Organisms
7%
Asthma
7%
Pharmacokinetics
7%
Klebsiella pneumoniae
7%
MIC90
7%
Incidence
7%
Medicine and Dentistry
Pneumonia
57%
Pazufloxacin
35%
Adverse Drug Reaction
28%
Bacterial Pneumonia
21%
Adverse Event
14%
Therapeutic Procedure
14%
Injection Site
7%
Pharmacokinetics
7%
Klebsiella pneumoniae
7%
Antiinfective Agent
7%
Haemophilus influenzae
7%
Moraxella catarrhalis
7%
Streptococcus Pneumoniae
7%
Quinolone Derivative
7%
Idiopathic Interstitial Pneumonia
7%
Asthma
7%
Drug Administration
7%
Inpatient
7%
Adjustment
7%
Incidence
7%
Ensure
7%
Pharmacology, Toxicology and Pharmaceutical Science
Pneumonia
57%
Pazufloxacin
35%
Adverse Drug Reaction
28%
Bacterial Pneumonia
21%
Adverse Event
14%
Pharmacokinetics
7%
Klebsiella pneumoniae
7%
Antiinfective Agent
7%
Quinolone Derivative
7%
Streptococcus Pneumoniae
7%
Haemophilus influenzae
7%
Moraxella catarrhalis
7%
Asthma
7%
Organisms
7%
Interstitial Pneumonia
7%
Incidence
7%
Ensure
7%
Biochemistry, Genetics and Molecular Biology
Minimum Inhibitory Concentration
35%
Maximum Concentration
28%
Clinical Study
21%
Dose
21%
Organisms
7%
Pharmacokinetics
7%
Streptococcus Pneumoniae
7%
Haemophilus influenzae
7%
Klebsiella pneumoniae
7%
MIC90
7%
Moraxella catarrhalis
7%
Adjustment
7%
Incidence
7%
Neuroscience
Pneumonia
85%
Pazufloxacin
35%
Pharmacokinetics
7%
Antimicrobials
7%
Streptococcus Pneumoniae
7%